Remedi SeniorCare has been acquired by Clarest Health
Overview
Deal Type |
Mergers & Acquisitions |
---|---|
Client & Transactional Partners |
Remedi SeniorCare Clarest Health |
Our Role |
Sell-Side Advisor |
Summary
Cain Brothers, a division of KeyBanc Capital Markets, served as the exclusive financial advisor to Remedi SeniorCare on its sale to Clarest Health, a portfolio company of Sverica Capital.
Cain Brothers was engaged to serve as Remedi’s exclusive financial advisor based on its deep sector knowledge and long-standing buyer relationships. This transaction further highlights Cain Brothers’ strong reputation for highly successful M&A processes and knowledge within the pharmacy and broader post-acute sectors.
Remedi is a pharmacy innovator that serves skilled nursing, assisted living, and independent living facilities throughout the United States. The Company leverages its proprietary technology, PAXIT, to deliver innovative packaging and medication management systems that drive cost savings and efficient medication passes.
Clarest is a growth-oriented pharmacy that partners with providers, patients, and caregivers within care facilities and at home. Differentiated on strong customer service and operational excellence, Clarest offers personalized medication management to more than 40,000 clients across 300 locations and 12 states. Sverica acquired a majority interest in Clarest in 2020, and invested alongside the founding management team to drive national expansion.
KeyBanc Capital Markets is a trade name under which the corporate and investment banking products and services of KeyCorp and its subsidiaries, KeyBanc Capital Markets Inc., member FINRA/SIPC (“KBCMI”), and KeyBank National Association (“KeyBank N.A.”), are marketed. Securities products and services are offered by KeyBanc Capital Markets Inc. and by its licensed securities representatives. Banking products and services are offered by KeyBank N.A.